159 related articles for article (PubMed ID: 33482350)
1. The relationship between hypoxia-inducible factor 1α (HIF-1α) and patient survival in breast cancer: Systematic review and meta-analysis.
Shamis SAK; McMillan DC; Edwards J
Crit Rev Oncol Hematol; 2021 Mar; 159():103231. PubMed ID: 33482350
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 1α in breast cancer prognosis.
Wang W; He YF; Sun QK; Wang Y; Han XH; Peng DF; Yao YW; Ji CS; Hu B
Clin Chim Acta; 2014 Jan; 428():32-7. PubMed ID: 24482805
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL
Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1 alpha (HIF-1α) as a prognostic indicator in patients with gastric tumors: a meta-analysis.
Zhang ZG; Zhang QN; Wang XH; Tian JH
Asian Pac J Cancer Prev; 2013; 14(7):4195-8. PubMed ID: 23991975
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V
Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis.
Zheng SS; Chen XH; Yin X; Zhang BH
PLoS One; 2013; 8(6):e65753. PubMed ID: 23799043
[TBL] [Abstract][Full Text] [Related]
12. The relationship between carbonic anhydrase IX (CAIX) and patient survival in breast cancer: systematic review and meta-analysis.
Shamis SAK; Edwards J; McMillan DC
Diagn Pathol; 2023 Apr; 18(1):46. PubMed ID: 37061698
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB
Clin Cancer Res; 2006 Aug; 12(15):4562-8. PubMed ID: 16899602
[TBL] [Abstract][Full Text] [Related]
14. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth.
Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X
Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G
Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer.
Dong M; Fan XJ; Chen ZH; Wang TT; Li X; Chen J; Lin Q; Wen JY; Ma XK; Wei L; Ruan DY; Lin ZX; Liu Q; Wu XY; Wan XB
Oncol Rep; 2014 Sep; 32(3):1101-7. PubMed ID: 25017254
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.
Yamamoto Y; Ibusuki M; Okumura Y; Kawasoe T; Kai K; Iyama K; Iwase H
Breast Cancer Res Treat; 2008 Aug; 110(3):465-75. PubMed ID: 17805961
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis.
Han S; Huang T; Hou F; Yao L; Wang X; Wu X
Ther Adv Med Oncol; 2019; 11():1758835919875851. PubMed ID: 31579115
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis.
Chen Z; He X; Xia W; Huang Q; Zhang Z; Ye J; Ni C; Wu P; Wu D; Xu J; Qiu F; Huang J
PLoS One; 2013; 8(12):e80337. PubMed ID: 24324596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
